Feed Item (AI Text)
Title: 💰⏳Own a Piece of the Patent Portfolio Behind the First Clinically Proven Dual-Pathway Anti-Inflammatory OTC Drug | Sen-Jam Pharmaceutical
Canonical URL: https://wefunder.com/feed/269718
Published at: 2026-03-03 14:36:18 UTC
Updated at: 2026-03-05 11:39:27 UTC

Content summary:
Dear Wefunder Investors & Community, Most pharmaceutical investors never get the chance to own a fractional interest in a global patent portfolio. At Sen-Jam, we believe in returning capital to our investors as soon as possible — and we create...

Key claims:
- Title: 💰⏳Own a Piece of the Patent Portfolio Behind the First Clinically Proven Dual-Pathway Anti-Inflammatory OTC Drug | Sen-Jam Pharmaceutical | citation: https://wefunder.com/feed/269718#claim-feed-item-title
- Published at: 2026-03-03 14:36:18 UTC | citation: https://wefunder.com/feed/269718#claim-feed-item-published-at

Author: Jim Iversen
Subject: Sen-Jam Pharmaceutical
Entity ID: wefunder:feed_item:269718